Flerie
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.
NET ASSET VALUE – 30 June 2026
MARKN.
On the 30 June 2026 Flerie AB's Net Asset Value (NAV) was SEK 3,394 million and NAV per share was SEK 39.14. Return on NAV* in the month was -2.1%.
| Allocation of NAV | Share of portfolio company | Fair value (MSEK) | Part of NAV per share (SEK) | Share of NAV |
| Product Development | ||||
| Lipum | 100% | 348 | 4.01 | 10.3% |
| Prokarium | 50% | 287 | 3.31 | 8.5% |
| KAHR Medical | 34% | 209 | 2.41 | 6.2% |
| Empros Pharma | 79% | 204 | 2.36 | 6.0% |
| Atrogi | 44% | 197 | 2.27 | 5.8% |
| Bonsai Biotherapeutics | 100% | 158 | 1.82 | 4.6% |
| Microbiotica | 10% | 129 | 1.48 | 3.8% |
| Xspray Pharma | 17% | 119 | 1.38 | 3.5% |
| Xintela | 60% | 102 | 1.17 | 3.0% |
| Mendus | 23% | 81 | 0.94 | 2.4% |
| AnaCardio | 13% | 79 | 0.92 | 2.3% |
| Geneos Therapeutics | 12% | 70 | 0.80 | 2.1% |
| Vitara Biomedical | 11% | 55 | 0.63 | 1.6% |
| EpiEndo Pharmaceuticals | 9% | 55 | 0.63 | 1.6% |
| Buzzard Pharmaceuticals | 15% | 33 | 0.38 | 1.0% |
| Egetis Therapeutics | 1% | 29 | 0.33 | 0.8% |
| Amarna Therapeutics | 58% | 11 | 0.13 | 0.3% |
| Strike Pharma | 18% | 11 | 0.12 | 0.3% |
| Total | 2,177 | 25.12 | 64.2% | |
| Commercial Growth | ||||
| Symcel | 30% | 204 | 2.36 | 6.0% |
| NorthX Biologics | 61% | 202 | 2.33 | 5.9% |
| Chromafora | 28% | 137 | 1.59 | 4.1% |
| Nanologica | 50% | 79 | 0.91 | 2.3% |
| Frontier Biosolutions | 2% | 27 | 0.31 | 0.8% |
| Bohus Biotech | 45% | 22 | 0.26 | 0.7% |
| Total | 672 | 7.75 | 19.8% | |
| Assets related to Portfolio companies | 237 | 2.74 | 7.0% | |
| Other assets and liabilities | 307 | 3.54 | 9.1% | |
| Net Asset Value | 3,394 | 39.14 | 100.0% | |
* Following the bonus issue of 11,888,785 shares conducted in May and followed by a cancellation of 8,412,578 shares in June, the return for the month is calculated on total NAV instead of as previously NAV per share.
| Datum | 2026-07-02, kl 08:00 |
| Källa | MFN |